WEBAF 2022

Barcelona, Spain

Waters European Biopharma Analytical Forum 2022

 

Claire Butré, R&D Technical leader, took part to WEBAF 2022 organised by Waters and presented the closing keynote on 20th October on Multiple-Attribute Monitoring in QC: feasibility and alternative to the bottom-up approach

 

Access the slides of her presentation here

Conference-Multiple Attribute Monitoring in QC

 

WEBAF is a two day, interactive in-person only event for the European biopharma community. It is a unique opportunity to learn from experts from the most exciting biopharma industries, exchange ideas and tips with peers and feel part of an ever-growing community.The agenda is a balanced mix of keynote lectures, parallel sessions and panel discussions.

Topics:

  • Bioprocess
  • Characterization and Monitoring
  • Advanced Characterization
  • Bioseparation

During her talk, Claire Butré presented Quality Assistance approach for for Multiple-Attribute Monitoring. Inter-laboratory study, analysis at subunit level or use of 2D-LC/MS for a fully automated workflow were also discussed during the closing keynote.

 

Quality-Assistance-WEBAF

 

ALWAYS AT THE FOREFRONT OF ANALYTICAL SERVICES

Quality Assistance is always at the forefront of analytical sciences, constantly investing in the latest technology and equipment. Our highly qualified teams always seek to deliver the highest quality services.

For each client project, we define analytical protocols, develop and validate specific new (bio)analytical methods and perform testing in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Thanks to our thorough regulatory, scientific and technical monitoring and skilled teams, we commit to providing the highest quality services and generating reliable data to enable our clients to consistently market safe products.

VENUE:

GRAN HOTEL REY DON JAIME

Avda,del Hotel, 22,08860 Castelldefels

Barcelona

Spain

MORE INFO about this event:

WEBAF 2022

Speed up the development of your product. Contact us for more information: